These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2219608)

  • 41. Role of the urinary calcium in the growth of calcium stone.
    Murayama T; Sakai N; Takano T; Yamada T
    Hinyokika Kiyo; 2004 Jul; 50(7):451-5. PubMed ID: 15334887
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
    Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
    J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Possibilities for preventing recurrent calcium stone formation: principles for the metabolic evaluation of patients with calcium stone disease.
    Tiselius HG;
    BJU Int; 2001 Jul; 88(2):158-68. PubMed ID: 11446874
    [No Abstract]   [Full Text] [Related]  

  • 44. Stone composition and metabolic study in urinary calculous disease.
    Tan EC; Tung KH; Low CO; Foong WC; Foo KT
    Ann Acad Med Singap; 1984 Oct; 13(4):616-9. PubMed ID: 6529146
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Inluence of osteoporosis and its causative factors on the prevention of recurrence of urinary stone disease].
    Demidko LS; Rudenko VI; Fadeev VV; Demidko YL; Amosov AV; Kuzmicheva GM; Grigoryan VA; Enikeev ME; Amosova MV
    Urologiia; 2019 Sep; (4):26-31. PubMed ID: 31535801
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Change in inhibitory potential in urine of hyperuricosuric calcium oxalate stone formers effected by allopurinol and orthophosphates.
    Goldwasser B; Sarig S; Azoury R; Wax Y; Hirsch D; Perlberg S; Many M
    J Urol; 1984 Nov; 132(5):1008-11. PubMed ID: 6492268
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Renal lithiasis in Lebanon: I--the chemical types of urinary calculi.
    Saksouk FA; Hemady K; Salti IS
    J Med Liban; 1980; 31(1):81-7. PubMed ID: 16295330
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute acid load in recurrent oxalate stone formers.
    Knispel HH; Fitzner R; Kaiser M; Butz M
    Urol Int; 1988; 43(2):93-6. PubMed ID: 3388639
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Value of repeated analyses of 24-hour urine in recurrent calcium urolithiasis.
    Höbarth K; Hofbauer J; Szabo N
    Urology; 1994 Jul; 44(1):20-4; discussion 24-5. PubMed ID: 8042263
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of a single evening dose of alkaline citrate on urine composition and calcium stone formation.
    Berg C; Larsson L; Tiselius HG
    J Urol; 1992 Sep; 148(3 Pt 2):979-85. PubMed ID: 1507355
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urinary stone analysis of 1,000 patients in southern Taiwan.
    Chou YH; Li CC; Wu WJ; Juan YS; Huang SP; Lee YC; Liu CC; Li WM; Huang CH; Chang AW
    Kaohsiung J Med Sci; 2007 Feb; 23(2):63-6. PubMed ID: 17339167
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences.
    Borghi L; Meschi T; Guerra A; Novarini A
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S78-86. PubMed ID: 7508066
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Parathyroid hormone and electrolytes during long-term treatment with allopurinol and thiazide.
    Kohri K; Takada M; Katoh Y; Kataoka K; Iguchi M; Yachiku S; Kurita T
    Br J Urol; 1987 Jun; 59(6):503-7. PubMed ID: 3690177
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiographic and laboratory data ("the Megaprofile") can accurately guide medical management in the absence of stone analysis.
    Best SL; Sivalingam S; Penniston KL; Nakada SY
    J Endourol; 2015 Mar; 29(3):357-61. PubMed ID: 25025627
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Current status of prevention and therapy of urinary calculi and peroral chemo-litholysis with special attention to the relationship of increased excretion of uric acid in oxalate lithiasis].
    Leskovar P
    Z Urol Nephrol; 1980 Mar; 73(3):229-39. PubMed ID: 7434987
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The experimental and clinical studies on the urinary calculi with the special reference to the metabolism of uric acid. Report II: relationship between urinary uric acid excretion and recurrent urinary oxalate containing calculus formation with special reference to the prevention of recurrence of formation (author's transl)].
    Kawamura T
    Nihon Hinyokika Gakkai Zasshi; 1975 Oct; 66(10):661-71. PubMed ID: 1240543
    [No Abstract]   [Full Text] [Related]  

  • 57. The effect of allopurinol on urinary oxalate excretion in stone formers.
    Scott R; Paterson PJ; Mathieson A; Smith M
    Br J Urol; 1978 Dec; 50(7):455-8. PubMed ID: 753494
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
    Sakhaee K; Poindexter JR; Griffith CS; Pak CY
    J Urol; 2004 Sep; 172(3):958-61. PubMed ID: 15311008
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Results of long-term rice bran treatment on stone recurrence in hypercalciuric patients.
    Ebisuno S; Morimoto S; Yasukawa S; Ohkawa T
    Br J Urol; 1991 Mar; 67(3):237-40. PubMed ID: 1902388
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Graphic display of urinary risk factors for renal stone formation.
    Pak CY; Skurla C; Harvey J
    J Urol; 1985 Nov; 134(5):867-70. PubMed ID: 4057368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.